News

Business Wire6mon
Onchilles Pharma Presents New Preclinical Data for the Systemically Delivered NEU-002 Program Targeting the ELANE Pathway at SITC 2024
Onchilles Pharma is a global drug discovery and development company focused on harnessing the ELANE pathway to create next-generation, pan-cancer therapeutics. These first-in-class medicines hold ...
Morningstar1mon
Onchilles Pharma Presents New Data at AACR 2025 Highlighting N17350, a Next-Generation Cytotoxic Therapeutic Leveraging the ELANE Pathway
“These results demonstrate the strength of leveraging the ELANE pathway to therapeutically ... Onchilles Pharma is a global drug discovery and development company pioneering first-in-class ...
Business Insider7y
Neutrophil Elastase (Bone Marrow Serine Protease or Elastase 2 or Medullasin or PMN Elastase or Human Leukocyte Elastase or ELANE or EC 3.4.21.37) - Pipeline Review, H2 2017
LONDON, Aug. 31, 2017 /PRNewswire/ -- Neutrophil Elastase (Bone Marrow Serine Protease or Elastase 2 or Medullasin or PMN Elastase or Human Leukocyte Elastase or ELANE or EC 3.4.21.37 ...